Related Experiment Video
Updated: Jun 15, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia
1Department of Pediatrics, JR Sapporo Hospital, Chuo-ku, Sapporo, Japan. naritamy@d5.dion.ne.jp
Abstract:
Although pneumonia has been a hallmark of Mycoplasma pneumoniae infection, it has been revealed that this infection can cause a number of extrapulmonary manifestations in the absence of pneumonia. While the host immune response has been implicated in the pathomechanism of pneumonia, the pathomechanisms of extrapulmonary manifestations remain largely unknown. It is proposed in this review that extrapulmonary manifestations due to M. pneumoniae infection can be classified into three categories; the first is a direct type in which inflammatory cytokines locally induced by lipoproteins contained in the bacterial cell membrane must play a role, the second is an indirect type in which immune modulation such as autoimmunity through cross-reaction between the bacterial cell components and human cells must play a role, and the third is a vascular occlusion type in which vasculitis and/or thrombosis with or without systemic hypercoagulable state induced by the bacterium must play a role. Based on this classification, a literature review was carried out for extrapulmonary manifestations due to M. pneumoniae infection with special reference to pneumonia, including cardiovascular, dermatological, digestive organ, hematological/hematopoietic system, musculoskeletal, sensory organ, and urogenital tract manifestations. Consequently, most extrapulmonary manifestations due to M. pneumoniae infection can be reasonably classified into and explained by one of the three types of pathomechanisms mentioned above. Noticeably in this review, Kawasaki disease and infectious mononucleosis in association with M. pneumoniae infection, which are not unusual in Japan but have seldom been reported from Western countries, are included in the panel of extrapulmonary manifestations due to M. pneumoniae infection.
Insights
Mycoplasma pneumoniae infections can cause extrapulmonary issues beyond pneumonia. This review classifies these manifestations into direct, indirect, and vascular occlusion types, explaining their mechanisms.
Area of Science:
- Infectious Diseases
- Immunology
- Pathology
Background:
- Mycoplasma pneumoniae commonly causes pneumonia.
- Extrapulmonary manifestations of M. pneumoniae are increasingly recognized.
- The underlying mechanisms of these extrapulmonary conditions are not well understood.
Purpose of the Study:
- To review and classify extrapulmonary manifestations of M. pneumoniae infection.
- To propose and evaluate pathomechanisms for these manifestations.
- To highlight specific conditions like Kawasaki disease and infectious mononucleosis.
Main Methods:
- Literature review of M. pneumoniae-associated extrapulmonary manifestations.
- Classification of manifestations based on proposed pathomechanisms: direct, indirect, and vascular occlusion.
- Analysis of cardiovascular, dermatological, hematological, and other organ systems.
Main Results:
- Extrapulmonary manifestations can be categorized into direct (cytokine-mediated), indirect (autoimmunity), and vascular occlusion (vasculitis/thrombosis) types.
- The proposed pathomechanisms explain most observed extrapulmonary conditions.
- Conditions like Kawasaki disease and infectious mononucleosis are discussed in the context of M. pneumoniae infection.
Conclusions:
- M. pneumoniae infection can lead to diverse extrapulmonary complications.
- The proposed three-type classification provides a framework for understanding these mechanisms.
- Further research is needed to fully elucidate the pathobiology of M. pneumoniae-induced extrapulmonary diseases.
Related Concept Videos
Atypical Pneumonia
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...